BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 507333)

  • 21. [Effect of treatment with synthetic progestins on indices of the liver protein-forming function in uterine cancer patients].
    Shvedova LA
    Akush Ginekol (Mosk); 1984 Apr; (4):51-2. PubMed ID: 6742352
    [No Abstract]   [Full Text] [Related]  

  • 22. [Characteristics of the reproductive function in genital endometriosis before and after the use of synthetic progestins].
    Shinkareva LF; Nagovitsyna AI; Sabsaĭ MI; Serebrennikova KG
    Vopr Okhr Materin Det; 1977 Dec; 22(12):60-5. PubMed ID: 341510
    [No Abstract]   [Full Text] [Related]  

  • 23. [Change of gonadotropic function of the hypophysis under the effect of synthetic progestins in dysfunctional uterine hemorrhage].
    Manuilova IA; Pshenichnikova TIa; sokolova ZP; Orlova VG; Kotliarskaia EI
    Akush Ginekol (Mosk); 1974 Aug; 0(8):13-7. PubMed ID: 4408809
    [No Abstract]   [Full Text] [Related]  

  • 24. [Estrogen excretion during testosterone and progestagen therapy of dysfunctional climacteric hemorrhage].
    Aronovich AS; Manuilova IA
    Sov Med; 1969 Aug; 32(8):14-7. PubMed ID: 5381914
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative evaluation of the treatment of dysfunctional uterine hemorrhages based on data from the Armenian Institute of Obstetrics and Gynecology].
    Melik-Alaverdian NI; Kagramanian RG; Khachatrian ML; Eolian ES; Kalantarova EG
    Zh Eksp Klin Med; 1972; 12(2):86-93. PubMed ID: 4662171
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthetic progestins in the management of anovulatory dysfunctional uterine bleeding.
    TAYMOR ML; STURGIS SH
    Obstet Gynecol; 1961 Jun; 17():751-7. PubMed ID: 13775666
    [No Abstract]   [Full Text] [Related]  

  • 27. [Degree of estrogen stimulation and the endometrial histostructure in dysfunctional uterine hemorrhages].
    Grishchenko VI; Shcherbina NA
    Akush Ginekol (Mosk); 1979 Oct; (10):27-9. PubMed ID: 507331
    [No Abstract]   [Full Text] [Related]  

  • 28. [State of the hypothalamo-hypophyseal system in girls with dysfunctional uterine hemorrhages before, during and after treatment with sex steroids].
    Antipina NN
    Akush Ginekol (Mosk); 1977 Feb; (2):13-6. PubMed ID: 900366
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment effectiveness in dysfunctional uterine hemorrhages using the gestagen, Norcolut].
    Prilepskaia VN; Kulakov VI; Baklaenko NG; Laricheva IP
    Akush Ginekol (Mosk); 1979 Oct; (10):29-31. PubMed ID: 507332
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of dysfunctional uterine hemorrhages by chorionic gonadotropins].
    Savchenko ON; Sokolov EG; Khrustaleva GF; Iakubov IuK
    Akush Ginekol (Mosk); 1969 Mar; 45(3):40-3. PubMed ID: 5406957
    [No Abstract]   [Full Text] [Related]  

  • 31. [Role of allergic factor in the pathogenesis of some forms of dysfunctional uterine hemorrhages].
    Vorontsov AA; Lukashchuk VA
    Akush Ginekol (Mosk); 1970 Aug; 46(8):36-9. PubMed ID: 5494418
    [No Abstract]   [Full Text] [Related]  

  • 32. [The functional state of the liver in patients with dysfunctional uterine bleeding in the climacteric period].
    Ivanov BK
    Zh Eksp Klin Med; 1967; 7(4):56-9. PubMed ID: 5633523
    [No Abstract]   [Full Text] [Related]  

  • 33. Noncontraceptive applications of the levonorgestrel intrauterine system.
    Jensen JT
    Curr Womens Health Rep; 2002 Dec; 2(6):417-22. PubMed ID: 12429074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Some biochemical indices in functional (dysfunctional) uterine hemorrhage].
    Iakubov Iu; Tarylov S
    Akush Ginekol (Mosk); 1966 Jun; 42(6):58-60. PubMed ID: 5988377
    [No Abstract]   [Full Text] [Related]  

  • 35. [Sequental estrogen-progestogen treatment and hepatic function in the climacteric age].
    Cazzola D
    Ann Ostet Ginecol Med Perinat; 1969 Nov; 91(11):756-73. PubMed ID: 5403945
    [No Abstract]   [Full Text] [Related]  

  • 36. [Artificial progestogens and functional uterine hemorrhages].
    Ferin J
    Gynecol Prat; 1965; 16():139-45. PubMed ID: 5878501
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of diffuse mastopathies with synthetic progestins].
    Balaeva GV
    Sov Med; 1986; (8):116-8. PubMed ID: 3775506
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pathogenesis of dysfunctional uterine hemorrhages].
    Dobrotina AF; Khamad'ianov UR
    Sov Med; 1973 Apr; 36(4):110-4. PubMed ID: 4769983
    [No Abstract]   [Full Text] [Related]  

  • 39. [Functional uterine hemorrhages].
    Greenblatt RB; Faucher GL
    Gynecol Prat; 1965; 16():1-15. PubMed ID: 5878507
    [No Abstract]   [Full Text] [Related]  

  • 40. Estrogens and progestins: what to use and how to use it.
    Jones KP
    Clin Obstet Gynecol; 1992 Dec; 35(4):871-83. PubMed ID: 1451370
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.